David A. Hosford
2013
In 2013, David A. Hosford earned a total compensation of $549.3K as Vice President, Clinical Development and Regulatory Affairs at Catalyst Biosciences, a 6% increase compared to previous year.
Compensation breakdown
| Bonus | $113,731 |
|---|---|
| Option Awards | $142,110 |
| Salary | $283,250 |
| Other | $10,200 |
| Total | $549,291 |
Hosford received $283.3K in salary, accounting for 52% of the total pay in 2013.
Hosford also received $113.7K in bonus, $142.1K in option awards and $10.2K in other compensation.
Rankings
In 2013, David A. Hosford's compensation ranked 9,012th out of 12,286 executives tracked by ExecPay. In other words, Hosford earned more than 26.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,012 out of 12,286 | 27th |
Division Manufacturing | 3,289 out of 4,612 | 29th |
Major group Chemicals And Allied Products | 1,047 out of 1,462 | 28th |
Industry group Drugs | 802 out of 1,156 | 31st |
Industry Pharmaceutical Preparations | 633 out of 890 | 29th |
Source: SEC filing on April 18, 2014.
Hosford's colleagues
We found six more compensation records of executives who worked with David A. Hosford at Catalyst Biosciences in 2013.
2013
Nassim Usman
Catalyst Biosciences
Chief Executive Officer
2013
Alan Musso
Catalyst Biosciences
Chief Financial Officer
2013
Stephen Hill
Catalyst Biosciences
Chief Executive Officer
2013
Peter Zorn
Catalyst Biosciences
General Counsel
2013
Patrick Rock
Catalyst Biosciences
General Counsel
2013
Edwin Madison
Catalyst Biosciences